Complement Activation during Critical Illness: Current Findings and an Outlook in the Era of COVID-19

被引：13
作者：
Bosmann, Markus [1 ,2 ]
机构：
[1] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 202卷 / 02期
关键词：
D O I：
10.1164/rccm.202005-1926ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：163 / 165
页数：4
相关论文
共 14 条
  • [1] Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness
    Bain, William
    Li, Huihua
    van der Geest, Rick
    Moore, Sara R.
    Olonisakin, Tolani F.
    Ahn, Brian
    Papke, Erin
    Moghbeli, Kaveh
    DeSensi, Rebecca
    Rapport, Sarah
    Saul, Melissa
    Hulver, Mei
    Xiong, Zeyu
    Mallampalli, Rama K.
    Ray, Prabir
    Morris, Alison
    Ma, Lina
    Doi, Yohei
    Zhang, Yingze
    Kitsios, Georgios D.
    Kulkarni, Hrishikesh S.
    McVerry, Bryan J.
    Ferreira, Viviana P.
    Nouraie, Mehdi
    Lee, Janet S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (02) : 230 - 240
  • [2] Blanco-Melo D, 2020, SARS COV 2 LAUNCHES
  • [3] Role of C3, C5 and Anaphylatoxin Receptors in Acute Lung Injury and in Sepsis
    Bosmann, Markus
    Ward, Peter A.
    [J]. CURRENT TOPICS IN INNATE IMMUNITY II, 2012, 946 : 147 - 159
  • [4] Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis?
    Campbell, Courtney M.
    Kahwash, Rami
    [J]. CIRCULATION, 2020, 141 (22) : 1739 - 1741
  • [5] Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
    Gralinski, Lisa E.
    Sheahan, Timothy P.
    Morrison, Thomas E.
    Menachery, Vineet D.
    Jensen, Kara
    Leist, Sarah R.
    Whitmore, Alan
    Heise, Mark T.
    Baric, Ralph S.
    [J]. MBIO, 2018, 9 (05):
  • [6] Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV
    Jiang, Yuting
    Zhao, Guangyu
    Song, Nianping
    Li, Pei
    Chen, Yuehong
    Guo, Yan
    Li, Junfeng
    Du, Lanying
    Jiang, Shibo
    Guo, Renfeng
    Sun, Shihui
    Zhou, Yusen
    [J]. EMERGING MICROBES & INFECTIONS, 2018, 7
  • [7] Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
    Kelly, Richard J.
    Hill, Anita
    Arnold, Louise M.
    Brooksbank, Gemma L.
    Richards, Stephen J.
    Cullen, Matthew
    Mitchell, Lindsay D.
    Cohen, Dena R.
    Gregory, Walter M.
    Hillmen, Peter
    [J]. BLOOD, 2011, 117 (25) : 6786 - 6792
  • [8] Magro C, 2020, TRANSL RES, DOI [10.1016/j.trsl.2020.04.007-0., DOI 10.1016/J.TRSL.2020.04.007-0.]
  • [9] The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
    Mastaglio, Sara
    Ruggeri, Annalisa
    Risitano, Antonio M.
    Angelillo, Piera
    Yancopoulou, Despina
    Mastellos, Dimitrios C.
    Huber-Lang, Markus
    Piemontese, Simona
    Assanelli, Andrea
    Garlanda, Cecilia
    Lambris, John D.
    Ciceri, Fabio
    [J]. CLINICAL IMMUNOLOGY, 2020, 215
  • [10] Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
    Pittock, S. J.
    Berthele, A.
    Fujihara, K.
    Kim, H. J.
    Levy, M.
    Palace, J.
    Nakashima, I.
    Terzi, M.
    Totolyan, N.
    Viswanathan, S.
    Wang, K. -C.
    Pace, A.
    Fujita, K. P.
    Armstrong, R.
    Wingerchuk, D. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (07) : 614 - 625
12